Amaç: Keratokonusta kornea kollajen çapraz bağlama sonrası kornea parametreleri (keratometre, kornea kalın-lığı, topografi indeksleri) değişikliklerini değerlendirmek.
INTRODUCTION
Keratoconus is a disease of the cornea characterized by progressive corneal stromal thinning and ectasia. Many treatment options like spectacles, contact lenses and keratoplasty are performed for the consequences of this disease. Besides these treatments, corneal collagen cross-linking addresses the pathophysiology of keratoconus and aims to stop the progression of this disease. Thus, this method of treatment lowered anxiety and improved vision-related and health-related quality of life in keratoconus patients [1] .
linking treatment there appears to be a keratocyte apoptosis period lasting 2-3 months and thereafter a repopulation occurs [3, 4] . There may be transient changes in human corneal endothelium following corneal collagen cross-linking [5] . Improved visual acuities, keratometric values and topography indices have been demonstrated in some studies [6] [7] [8] .
In this retrospective study we aimed to evaluate and depict the changes in corneal parameters (keratometry, corneal thickness, topography indices) for a minimum of 24 months follow-up following conventional corneal collagen cross-linking for progressive keratoconus.
METHODS
The medical records of the patients who underwent cross-linking treatment for keratoconus between April 1 st , 2008 and February 1 st , 2014 were reviewed and 10 eyes of 6 patients (2 women, 4 men) were included in this retrospective study. The inclusion criteria were; corneal topography pattern consistent with keratoconus, no previous surgery, having a minimum of 24 months follow-up, having had cross-linking treatment for once during the follow-up period, no additional corneal surgeries during the follow-up period, having at least 2 follow-up visits documented during the first year.
The corneal collagen cross-linking procedure was performed by the same surgeon (CBC) as described below. After routine preparation for eye surgeries, 0.5% proparacaine hydrochloride (Alcaine, Alcon Laboratories, Inc., USA) was instilled for topical anesthesia and the central 8.0 mm epithelium was scraped with a corneal scarifier. Standard riboflavin 0.1% (Medio-Cross D, Medio-Haus Medizinprodukte GmbH) was instilled every 2 minutes for 30 minutes. The corneal penetration of riboflavin was confirmed with visualization of the yellow colored riboflavin in the anterior chamber with a slit-lamp. CCT was measured with an ultrasonic pachymetry (Accutome AccuPach VI Pachymeter, Accutome Inc., Malvern, USA). If the corneal thickness was less than 400 µm, 1 drop of hypotonic riboflavin 0.1% (MedioCross H, Medio-Haus Medizinprodukte GmbH) was administered every 10 seconds for 2 minute sessions, after which ultrasound pachymetry was performed to confirm that the stroma was swollen to 400 µm or thicker. The procedure was proceeded by starting 365 nm UVA radiation (UV-X system, IROC AG, Zurich, Switzerland) at an irradiance of 3.0 mW/cm2. By adjusting the aperture, only the non-epithelialized cornea was irradiated and the limbal stem cells were avoided.
During the application of UVA radiation standard riboflavin 0.1% was also instilled every 2 minutes. For some of the patients' isotonic riboflavin (MedioCross M, Medio-Haus Medizinprodukte GmbH) was used in all parts of the procedure. When the 30 minutes of radiation treatment was over, the cornea was washed thoroughly with BSS. One drop of an antibiotic and a bandage contact lens were put on the eye. Contact lens was removed after epithelial healing. For the postoperative 1st week; treatment regimen was moxifloxacin hydrochloride ophthalmic solution 0.5% (Vigamox®, Alcon Laboratories, Inc., USA) 3 times daily, nepafenac ophthalmic suspension 0.1% (Nevanac®, Alcon Laboratories, Inc., USA) 3 times daily and artificial tear drops (Refresh®, Allergan Laboratories, Inc., USA) every hour. For the 2nd postoperative week loteprednol etabonate ophthalmic suspension 0.5% (Lotemax ®, Bausch&Lomb, Inc., Florida, USA) was used 4 times daily and artificial tear drops were used as needed. Lotemax® was tapered and discontinued during the following 2 weeks.
The objective refraction measurements were taken by Topcon KR 8900 Auto-Kerato-Refractometer (Topcon Corporation, Tokyo, Japan), the CCT and the keratometry values were obtained using Pentacam (Oculus Optikgeräte GmbH, Wetzlar, Germany), corneal topography indices were obtained by Wavelight-Allegretto Wave Topolyzer (WaveLight Technologie, AG, Erlangen, Germany). The best corrected visual acuity (BCVA) before the operation and at the final visit; Kmax, CCT values and topography indices: ISV, IVA, KI, CKI, Rmin, IHA, and IHD at each visit were recorded. The abnormal and pathologic values for these indices are presented in Table 1 [9] . 
DISCUSSION
Progressive thinning and bulging of the cornea is the main concern in follow-up and treatment of keratoconus. Increase in keratometric values, thinning of the cornea and deterioration of the corneal topography indices are observed in this disease course.
Stopping the increase or deterioration of these parameters is the main goal of the treatment.
Corneal collagen cross-linking arrests the progression of keratoconus by increasing the biomechanical stability of the cornea [2, [10] [11] [12] . This is achieved by formation of new covalent links between collagen fibrils. The findings in this study show that the Kmax, CCT and corneal topography indices remain steady even after a follow-up of 24-63 months.
Contact lenses had been described to arrest keratoconus but it hasn't been confirmed in a systematic study [13] . There are some studies showing the arrest of keratoconus by corneal collagen cross-linking in which no significant change was observed in keratometry values during the follow-up period [8, 14, 15] . Also some studies report improvement in keratometry readings and visual acuities after cross-linking treatment [5, 16, 17] . Wittig-Silva et al. reported a decrease in keratometry values of 0.72±0.15D in postoperative 1st year and this decrease increased to 1.03±0.19D in 3rd year [18] . In this study the mean Kmax values didn't differ from the preoperative values at the end of follow-up period.
There are some different modifications in corneal collagen cross-linking particularly to reduce the treatment time. Accelerated corneal collagen crosslinking became popular nowadays and has similar results with the conventional one [19, 20] .
The final postoperative mean CCT was nearly the same as the preoperative values in this study. Although most of the studies in the literature documented no statistically significant change in corneal thickness between preoperative and postoperative values, there are some others reporting significant decrease in corneal thickness after cross-linking treatment [18] [19] [20] [21] [22] [23] [24] . Performing corneal cross-linking procedure with isotonic riboflavin solution without dextran might not induce corneal thinning but a little swelling throughout the procedure. This could also be taken into consideration while evaluating the CCT [25] . Arbelaez et al. demonstrated a transient initial decrease in corneal thickness and after 3 months they observed a steady increase up to preoperative values [3] . To the best of our knowledge the retrospective study of Raiskup-Wolf et al. was the only study which demonstrated a significant increase in corneal thickness 2 years after crosslinking (+ 21±31 µm) [6] .
The main limitation of the study was the number of patients that were examined. It was hard to follow-up a patient for two years because after succesful corneal collagen cross-linking treatment the patient thought that disease was over. The other limitation was the retrospective nature of the study. Both of these limitations can be outreached with over two year prospective large group cohort studies in the future.
The stabilization and improvement in corneal topography indices were also shown in some previous studies. Sloot et al. found significant improvements in ISV, IVA, CKI, Rmin and IHD one year after cross-linking [26] . Toprak et al. demonstrated improvements in ISV, CKI and Rmin after cross-linking with a follow-up of 12 months [27] . Here in this study we found an improvement or at least stabilization in all topography indices for every case.
In conclusion, this study demonstrates the stability of corneal topographic parameters after 3 years mean follow-up period following conventional corneal collagen cross-linking for the treatment of progressive keratoconus.
